Suggestions
Paul Jansen
Device & Drug Device Consultant, Board Member (Haselmeier, Subcuject), Advisory Board Member (Evoleen)
There are multiple people named Paul Jansen.
Paul Jansen, Device & Drug Device Consultant: Paul Jansen is a drug/device consultant, advisor, and board member in the combination products space.1 He was formerly the Associate Vice President, Medical Device Development at Sanofi until he retired in January 2017.1 Currently, he works as a Drug Device Development Consultant and sits on the Advisory Boards of Evoleen, Windgap & Kymanox.1 He is also on the Board of Directors at Subcuject.1 Kymanox Corporation announced that Paul Jansen joined the Kymanox Executive Advisors (KEA) team in October 2022.8 Paul Jansen’s LinkedIn username is paulejansen.6
Jansen has over 30 years of experience in combination product development with long tenures with both Sanofi and Eli Lilly.8 He has extensive experience in the design, development, manufacturing, and lifecycle management of medical devices.4 He has multiple patents and has deep experience in the creation and management of intellectual property portfolios.14 He has successfully led teams that have developed and launched several award-winning devices, including Lantus SoloStar, the world’s most popular insulin pen injection device.14 In addition, he has expertise in the design and development of injection molding systems and electronic components.14 Until January 2022, Paul was the Chair of Technical Committee 84, Devices for the Administration of Medicinal Products and Catheters.1
Jansen holds a Bachelor’s degree in Applied Science and has completed graduate studies in Biomedical Engineering from the University of Toronto.8
Paul Jansen, Vice President of Data and Analytics: Paul Jansen is the Vice President of Data and Analytics at Valtruis.27 He is experienced in growing analytics teams that deliver actionable insights at scale.2 Most recently Paul led the value-based care team at Teladoc Health, developing successful value-based care models and assessing product impact on clinical outcomes and total cost of care savings.2 Prior to Teladoc, Paul led and grew the analytics function at Bright Health, providing insights to drive high quality, efficient care delivery in Individual Marketplaces and Medicare Advantage members in multiple states.2 He has also held roles at Blue Cross and Blue Shield of Minnesota, the Minnesota Department of Health, and in the Navy and Marine Corps Public Health Center.2 Paul Jansen's LinkedIn username is paul-jansen-1102678.7
Paul holds a Bachelor's Degree in Human Biology from Michigan State University and a Masters in Public Health in Epidemiology from the University of Minnesota.2
Paul Jansen, Adjunct Professor: Paul Jansen is an Adjunct Professor at Haas School of Business at the University of California, Berkeley.5 He co-teaches an MBA-level course called Social Sector Solutions and also teaches a course on Nonprofit Boards and governance and is currently doing research into ways to improve nonprofit governance.5 Paul Jansen's LinkedIn username is paul-jansen-3287456.5
He is also a Trustee at Susan Crown Exchange and a Director, Investor, and Advisor at Zymergen, Inc.5 Previously, he was a Supervisory Board member at CARE International, a Member of the Board of Directors and Chairman of the Board at CARE, a Director at San Francisco Zoo, and a Senior Partner at McKinsey & Company.5
Paul earned a Bachelor of Science in Chemical Engineering from the University of California, Berkeley, and an MBA from Harvard Business School.5
Paul Jansen, Senior Inspector and Environmental Technician: Paul Jansen is a senior inspector and environmental technician with Stantec's Water group.9 He has managed construction projects involving earthworks and roadways.9 Throughout his nearly 25 years of experience in the industry, Paul has developed an understanding of construction methods and can quickly and effectively develop strategies to mitigate risks and solve challenges as they arise.9
Dr. Paul Janssen, Founder of Janssen Pharmaceutical: Dr. Paul Janssen (1926-2003) was an innovative pharmaceutical researcher and the founder of Janssen Pharmaceutica.3 He and his research teams discovered more than 80 new molecules.3 At the time of his death in 2003, he held more than 100 patents and was a listed author on more than 850 scientific publications.3
